Status:
COMPLETED
Omega-3 Fatty Acid for Critically Ill Patients.
Lead Sponsor:
Menoufia University
Conditions:
Sepsis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Sepsis is the most common reason for intensive care unit (ICU) admission. Sepsis flares up the systemic inflammatory response with its mediators. Sepsis treatment protocols have been established in ma...
Detailed Description
A hundred and ten critically ill septic patients were included in the study. Patients were divided into two groups fifty-five patients each. Group A received enteral nutrition supplemented with Omega-...
Eligibility Criteria
Inclusion
- All septic patients who could receive enteral nutrition were included in the study
Exclusion
- Patients with end stage liver or renal disease, haemodynamic instability, immunosuppression, gastrointestinal comorbidity, allergic to omega-3, received omega-3 a week prior to ICU admission, patients who expected to live less than 24 hours, and patients who were mechanically ventilated on ICU admission were excluded from the study.
Key Trial Info
Start Date :
January 15 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2017
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03388450
Start Date
January 15 2015
End Date
November 30 2017
Last Update
January 3 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.